Peptide Library / Injury & Recovery / BPC-157
Peptide Guide · Injury & Recovery

BPC-157

A 15–amino acid peptide first studied for protecting the stomach lining. Now one of the most requested peptides for tendon, ligament, joint, and gut recovery.

FORMSInjectable
TYPICAL COURSE4–8 weeks, then a break
STATUSCompounded, Rx only
STATESWA ID MT UT AZ OH IL
See if it's right for you
Reviewed by Dr. Jason Wright, D.O. · September 23, 2026
BPC-157 ready-to-use liquid vial with a cream label, Rx only
The science

How it works

Builds new blood vessels
Upregulates VEGFR2, the receptor that drives new blood vessel growth, bringing circulation to tendons and ligaments that normally get very little.
Works through nitric oxide
Acts on the nitric oxide system that controls blood vessel tone and healing, one reason its effects show up across so many different tissues.
Rebuilds cell attachments
Activates the FAK–paxillin pathway, which lets tendon cells migrate, anchor, and rebuild the matrix around them.
Makes tendon cells more responsive
In lab studies it increases growth hormone receptor expression on tendon fibroblasts, so they respond more strongly to the body’s own repair signals.

Most of this comes from animal and cell research. The human studies so far are small, but their results have been encouraging.

Dosing

Your dosing plan

Dr. Wright sets your exact dose within this range at your visit.

Week 1
FormSubcutaneous
Dose300 mcg (10 units)
ScheduleOnce daily
Based onTolerance check
Standard dose
FormSubcutaneous
Dose600 mcg (20 units)
ScheduleOnce daily, 4–8 weeks
Based onPharmacy labeling, clinical practice
Split dose
FormSubcutaneous
Dose300 mcg (10 units) twice daily
ScheduleOnly if directed
Based onClinical practice
Gut-focused
FormOral capsule
Dose500 mcg (see BPC-157 Capsules)
ScheduleDaily, 4–8 weeks
Based onAnimal studies
Side effects

Side effects and what to expect

Redness or irritation at the injection site Common · First few weeks
Rotate sites. Let the vial reach room temperature first.
Nausea Uncommon · First doses
Usually passes. Let us know if it doesn’t.
Headache or dizziness Uncommon · First week
Stay hydrated and mention it at your follow-up.
Allergic reaction Rare · Any time
Stop and contact the practice.
Dr. Jason Wright, D.O.
A note from Dr. Wright

Tendons and ligaments are some of the slowest tissues in the body to heal because they get so little blood flow. That’s where BPC-157 has drawn the most interest. It’s also why I like combining it with hyperbaric oxygen therapy, which increases blood flow and lowers inflammation. The peptide supports the repair; the oxygen helps get it where it needs to go.

Dr. Jason Wright, D.O. · Board certified, American Board of Cosmetic Surgery
Cost & access

Getting started with BPC-157

BPC-157
15 mg in a 5 mL vial (3 mg/mL), ready to inject, no mixing · Labeled in your name
$120
+ $99 initial visit · shipping $15
Book a visit
15 mg liquid vial (3 mg/mL, 5 mL) $120
Questions

Common questions

How soon will I notice a difference?
Many patients report changes within 2 to 4 weeks. Tendons and ligaments heal slowly, so judge your results at the end of the course, not the first week.
Where do I inject it?
Always under the skin, never into a joint or tendon at home. Dr. Wright will show you where, usually the abdomen or near the injured area.
Can I keep taking ibuprofen?
Ask Dr. Wright first. Don’t stop or change a prescribed medication on your own.
Is BPC-157 legal?
Yes, when prescribed and compounded for you by a licensed 503A pharmacy. It is not FDA-approved. In July 2026 an FDA advisory committee recommended it for the compounding list, with final action pending.
Research

Supporting studies

Knee injections with BPC-157 relieved pain in 14 of 16 patients
Lee E, Padgett B. Alternative Therapies in Health and Medicine, 2021
PubMed →
A single dose resolved bladder pain symptoms in 10 of 12 women
Lee E, Walker C, Ayadi B. Alternative Therapies in Health and Medicine, 2024
PubMed →
Stable gastric pentadecapeptide BPC 157 and wound healing
Seiwerth S, et al. Frontiers in Pharmacology, 2021 (review)
Read →
BPC 157’s broad protective activity across tissues
Sikiric P, et al. Pharmaceuticals, 2024 (review)
Read →
IV BPC-157 was well tolerated in a small human safety pilot
Lee E, Burgess K. Alternative Therapies in Health and Medicine, 2025 (pilot)
PubMed →